Clinical Trial Update: Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of aripiprazole and ziprasidone in schizophrenia patients with metabolic syndrome; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)
• Geodon (Ziprasidone)

Snippet

Sponsor: University of Malaya | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED